How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

half-life, which Metsera said was at least as good as approved and clinical-stage drugs in the class, which include Novo Nordisk's Wegovy (semaglutide) and Eli Lilly's Zepbound (tirzepatide).

Metsera's lead asset is MET-097i, billed as an ultra-long-acting GLP-1 receptor agonist with a profile that could challenge Novo Nordisk's Wegovy (semaglutide) and Eli Lilly's Zepbound ...

it fits into the series chronologically between Half-Life 1 and 2. You are Alyx Vance, fighting against the Combine alongside her father, Eli. Though fans questioned the decision to develop the ...

Eli Lilly’s Ebglyss (lebrikizumab-lbkz ... Bambusa Therapeutics has announced the dosing of its first healthy volunteers as part of a Phase I trial on its half-life extended bispecific antibody ...

Caitlin Clark may be an all-star on the basketball court, but she couldn’t beat Eli Manning when it came to a game of Pop-A-Shot. On the latest episode of The Eli Manning Show, the former NFL ...

Eli Manning’s still got it — even off the football field. The legendary Giants quarterback, 44, faced off against WNBA star Caitlin Clark in a recent round of Pop-A-Shot on “The Eli Manning ...

Eli Lilly’s Ebglyss (lebrikizumab-lbkz) has achieved complete skin clearance after three years in 50% of patients with moderate-to-severe atopic dermatitis (AD) in a Phase III trial. The US ...

MariTide’s opportunity in diabetes should not be ignored. In addition to reducing weight by 17%, it reduced HbA1c up to 2.2% ...